Brief: ROVI FY Revenue EUR 763.7 Million Vs. IBES Estimate EUR 766 Million

Laboratorios Farmaceuticos Rovi

25/02/2025 06:48

Feb 25 (Reuters) - ROVI FY EBIT EUR 179.4 million.
* FY free cash flow EUR 76.2 million
* FY EBITDA EUR 207.4 million
* FY net income EUR 136.9 million